Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
In type 2 diabetes, glargine and liraglutide each improved glycemic outcomes at 5 y vs. glimepiride or sitagliptin.
Journal: Annals of internal medicine
Published: January 02, 2023
In type 2 diabetes, liraglutide reduced CV events at 5 y vs. glargine, glimepiride, or sitagliptin.
Journal: Annals of internal medicine
Published: January 02, 2023
Preparing Future Medicine Physicians to Care for Cancer Survivors: Project ECHO® in a Novel Internal Medicine and Family Medicine Residency Curriculum.
Journal: Journal of cancer education : the official journal of the American Association for Cancer Education
Published: March 28, 2022
In persons at intermediate risk for CVD, polypills reduce a composite of CV events at 5 y.
Journal: Annals of internal medicine
Published: January 03, 2022
In hypertension, a quadpill containing quarter doses of 4 BP drugs reduced BP at 12 wk vs. standard-dose monotherapy.
Journal: Annals of internal medicine
Published: January 03, 2022
In type 2 diabetes, early metformin plus vildagliptin reduced treatment failure vs a stepwise approach.
Journal: Annals of internal medicine
Published: February 18, 2020
In black Africans with hypertension, amlodipine-based therapy vs perindopril-hydrochlorothiazide improved BP control.
Journal: Annals of internal medicine
Published: July 16, 2019
Vibrio vulnificus infection and liver cirrhosis: a potentially lethal combination.
Journal: BMJ case reports
Published: May 07, 2016
Primary Cutaneous Peripheral T-Cell Lymphoma Not Otherwise Specified: A Rapidly Progressive Variant of Cutaneous T-Cell Lymphoma.
Journal: Case reports in oncological medicine
Published: July 14, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026